Flow chamber device uncovers new information that could prevent heart attacks and strokes
Friday, July 22, 2011
July 22 - University of Calgary's Schulich School of Engineering researchers, Kristina Rinker and Bob Shepherd, recently published a paper in the July issue of the American Journal of Physiology - Heart and Circulatory Physiology indicating that the presence of a particular form of the protein Smad2 appears to influence artery health. News release.
This new information on blood flow behavior and its influence on heart and mind health were recently discovered in a study using a flow chamber device designed by the University of Calgary's Schulich School of Engineering researchers, Kristina Rinker and Bob Shepherd. This device simulates blood flow over cells, allowing researchers to examine human cells under biologically relevant conditions and study behavioral parameters as a result of cell exposure to patterns of fluid flow.
Kristina Rinker and Bob Shepherd will continue to use the flow chamber system to broaden understanding and explore the development of new treatments for cardiovascular disease. Rinker and Shepherd are working with Innovate Calgary and Biovantage to commercialize the flow chamber device to expand its use into other industries such as pharmaceuticals to support the development of new medications and examine their efficacy within the bloodstream.